Cargando…
Genome-Wide Meta-Analysis and Mendelian Randomization Identify Early Biomarkers of Non-Alcoholic Fatty Liver Disease
Background: The diagnosis of non-alcoholic fatty liver disease (NAFLD) is often challenging. Blood-based biomarkers which are causally influenced by NAFLD and that are not modulated by secondary non-causal pathways, are promising candidates for the identification of patients with NAFLD. Objectives:...
Autores principales: | Gobeil, Emilie, Abner, Erik, Ghodsian, Nooshin, Taba, Nele, St-Amand, Alexis, Perrot, Nicolas, Couture, Christian, Mitchell, Patricia, Bossé, Yohan, Mathieu, Patrick, Vohl, Marie-Claude, Thériault, Sébastien, Tchernof, Andre, Esko, Tõnu, Arsenault, Benoit J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8090481/ http://dx.doi.org/10.1210/jendso/bvab048.643 |
Ejemplares similares
-
Electronic Health Record-Based Genome-Wide Meta-Analysis Identifies New Susceptibility Loci for Non-Alcoholic Fatty Liver Disease
por: Ghodsian, Nooshin, et al.
Publicado: (2021) -
Electronic health record-based genome-wide meta-analysis provides insights on the genetic architecture of non-alcoholic fatty liver disease
por: Ghodsian, Nooshin, et al.
Publicado: (2021) -
Mendelian Randomization Analysis Identifies Blood Tyrosine Levels as a Biomarker of Non-Alcoholic Fatty Liver Disease
por: Gobeil, Émilie, et al.
Publicado: (2022) -
Mendelian randomization prioritizes abdominal adiposity as an independent causal factor for liver fat accumulation and cardiometabolic diseases
por: Gagnon, Eloi, et al.
Publicado: (2022) -
Impact of the gut microbiota and associated metabolites on cardiometabolic traits, chronic diseases and human longevity: a Mendelian randomization study
por: Gagnon, Eloi, et al.
Publicado: (2023)